A double-blind comparative clinical trial with maprotiline (Ludiomil) and imipramine in newly-admitted depressed patients.
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D000704:Analysis of Variance; D000873:Anthracenes / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007099:Imipramine / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008376:Maprotiline / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012647:Self-Assessment
D000873:Anthracenes; D000928:Antidepressive Agents; D008376:Maprotiline; D007099:Imipramine